Replaces Prod. #: ALX-480-045
- Cell-permeable PKA activator
- Compound used to study neurogenesis
Dibutyryl-cAMP (DB-cAMP) is a cell-permeable cAMP analog that preferentially activates cAMP-dependent protein kinase (e.g. protein kinase A) and inhibits phosphodiesterases. Used together with other compounds, DB-cAMP increases survival rate and promote differentiation of neural stem/progenitor cells into neurons in vivo. DB-cAMP also has anti-inflammatory properties and can be used to facilitate wound healing. Caution: Due to extra- and intra-cellular esterases, DB-cAMP releases butyrate, which may have distinct biological effects.
Product Details
| Alternative Name: | Dibutyl cyclic AMP sodium salt, N6-2'-O-dibutyryladenosine-3',5'-cyclic monophosphate, DB-cAMP |
| |
| Formula: | C18H23N5O8P . Na |
| |
| MW: | 491.4 |
| |
| Source: | Synthetic. |
| |
| CAS: | 16980-89-5 |
| |
| Purity: | ≥98% (HPLC) |
| |
| Identity: | Identity determined by MS, 1H-NMR, 31P-NMR, and UV spectrum. |
| |
| Appearance: | White crystalline solid. |
| |
| Solubility: | Soluble in DMSO (200mM), 96% ethanol (25mM), or water (100mg/ml). |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | -20°C |
| |
| Use/Stability: | Solution must be stored in the refrigerator and should be lyophilized and frozen for longer storage periods. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
High-content phenotyping of Parkinson's disease patient stem cell-derived midbrain dopaminergic neurons using machine learning classification: A. Vuidel, et al.; Stem Cell Reports
17, 2349 (2022),
Abstract;
Intermediate cells of in vitro cellular reprogramming and in vivo tissue regeneration require desmoplakin: J. Ha, et al.; Sci. Adv.
8, eabk1239 (2022),
Abstract;
Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons: L.F. Ornelas, et al.; NPJ Parkinsons Dis.
8, 118 (2022),
Abstract;
Quantification of Neurite Degeneration with Enhanced Accuracy and Efficiency in an In Vitro Model of Parkinson’s Disease: R.T. Clements, et al.; eNeuro
9, ENEURO.0327-21.2022 (2022),
Abstract;
Identification of ASCL1 as a determinant for human iPSC-derived dopaminergic neurons: A.M. Earley, et al.; Sci. Rep.
11, 22257 (2021),
Abstract;
Simplified Brain Organoids for Rapid and Robust Modeling of Brain Disease: J. Ha, et al.; Front Cell Dev Biol
8, 594090 (2020),
Abstract;
Application of CRISPR/Cas9 editing and digital droplet PCR in human iPSCs to generate novel knock-in reporter lines to visualize dopaminergic neurons: C. Uberbacher, et al.; Stem Cell Res.
41, 101656 (2019),
Abstract;
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation: C. Sheng, et al.; Nat Commun.
9, 4047 (2018),
Abstract;
Full Text
Bacterial endosymbionts influence host sexuality and reveal reproductive genes of early divergent fungi: S.J. Mondo, et al.; Nat. Commun.
8, 1843 (2017),
Abstract;
Full Text
Cyclic nucleotide phosphodiesterase 1 regulates lysosome-dependent type I collagen protein degradation in vascular smooth muscle cells: Y. Cay, et al.; Arterioscler. Thromb. Vasc. Biol.
31, 616 (2011),
Abstract;
Full Text
Apoptosis of vascular smooth muscle cells. Protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in non-transformed rat vascular smooth muscle cells: D. Leszczynski et al.e; Am. J. Pathol.
145, 1265 (1994),
Abstract;
Transcription of the gene for parathyroid hormone-related peptide from the human is activated through a cAMP-dependent pathway by prostaglandin E1 in HTLV-I-infected T cells: K. Ikeda et al.; J. Biol. Chem.
268, 1174 (1993),
Abstract;
Up-regulation of oxytocin receptors in rabbit amnion by adenosine 3’,5’-monophosphate: A. Hinko & M.S. Soloff; Endocrinology
132, 126 (1993),
Abstract;
Lack of correlation between activation of cyclic AMP-dependent protein kinase and inhibition of contraction of rat vas deferens by cyclic AMP analogs: Y.-J. Hei et al.; Mol. Pharmacol.
39, 233 (1991),
Abstract;
Analogs of cyclic AMP and cyclic GMP: general methods of synthesis and the relationship of structure to enzymic activity: R.B. Meyer and J.P. Miller; Life Sci.
14, 1019 (1974),
Abstract;
The preparation of acylated derivatives of cyclic nucleotides: T. Posternak & G. Weimann; Methods Enzymol.
38, 399 (1974),
Abstract;
Related Products
